结直肠癌手术围术期益生菌对肠道功能恢复时间的影响(PICCS-1):一项随机对照试验的研究方案
该研究为平行三臂随机对照试验,比较无营养补充、Nestle Isocal营养补充及含副干酪乳杆菌的Nestle Boost Optimum营养补充对结直肠癌手术患者术后首次排便时间的影响。主要结局为首次排便时间,次要结局包括首次排气时间、感染并发症及营养补充相关不良事件,采用意向性治疗分析。
要点
- 术后肠梗阻在结直肠癌大型肿瘤手术后发生率高达30%,导致显著发病率、患者痛苦及医疗资源利用增加。
- 三臂分别为无营养补充、Nestle Isocal营养补充(无益生菌)、Nestle Boost Optimum营养补充(含副干酪乳杆菌)。
- 主要结局为首次排便时间(天),次要结局为首次排气时间、感染并发症及营养补充相关不良事件。
核心结论
- 该研究设计三臂随机对照试验以确定围术期益生菌联合营养补充是否能帮助减少术后肠梗阻发生率。
研究设计与样本
- 平行三臂随机对照试验。
- 第1臂不提供营养补充;第2臂提供Nestle Isocal营养补充(不含益生菌);第3臂提供Nestle Boost Optimum营养补充(含副干酪乳杆菌)。
- 主要结局为自手术当日起首次排便时间(天);次要结局为首次排气时间、感染并发症及营养补充相关不良事件。
- 统计分析采用意向性治疗(ITT)方法,连续变量用ANOVA及Tukey检验比较,分类变量用χ2检验。
主要发现
- 术后肠梗阻在结直肠癌大型肿瘤手术后发生率高达30%。
- 围术期给予益生菌迄今取得的成功不一致。
- Nestle Boost Optimum含有与Isocal相似的营养成分配比,但添加了副干酪乳杆菌。
关键数值与推荐
- 主要结局为首次排便时间,单位为天,自手术当日起计算。
- 次要结局包括首次排气时间、感染并发症及营养补充相关不良事件。
- 采用意向性治疗分析;连续变量用ANOVA及Tukey检验,分类变量用χ2检验。
临床怎么用
- 原文未据此给出推荐。
- 作者认为营养补充联合益生菌是便捷的非药片替代方案,且这些干预措施在世界各地许多医院的处方集中常见。
- 作者指出若成功,益生菌营养补充可能成为减少术后肠梗阻的成本效益简易方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative ileus occurs in up to 30% of patients following major oncologic surgery for colorectal cancer, leading to significant morbidity, patient distress, as well as increased utilization of healthcare resources. Various modalities to reduce postoperative ileus rates have been explored. One such modality is the perioperative administration of probiotics which have hitherto achieved inconsistent success. Here, we design a trial to determine whether the perioperative administration with probiotics given together with nutritional supplementation can help to reduce postoperative ileus rates. METHODS: We propose a parallel three-arm randomized controlled trial. In Arm 1, no nutritional supplementation is provided to the patient. In Arm 2, Nestle Isocal is provided to the participant. Nestle Isocal provides nutritional supplementation but without any probiotic. In Arm 3, Nestle Boost Optimum is provided to the patient. Nestle Boost Optimum contains a similar nutritional profile to Isocal, but with the addition of Lactobacillus paracasei. The primary outcome is the time to first bowel movement in days from the day of surgery. Secondary outcomes are time to first flatus, infective complications, and adverse events related to the administration of nutritional supplementation. Statistical analysis will be conducted in an intention-to-treat approach. ANOVA with the Tukey test will be used to compare continuous variables, while the χ2 test will be used for categorical variables. DISCUSSION: Nutritional supplementation with probiotics is a convenient, non-pill alternative for patients. Furthermore, the interventions are commonly found in the formulary of many hospitals worldwide. If successful, probiotics in nutritional supplementation could be a cost-effective and simple way to reduce postoperative ileus. TRIAL REGISTRATION: ClinicalTrials.gov NCT06456229. This trial was registered on 11 June 2024. Thai Clinical Trials Registry TCTR20240706003. This trial was registered on 6 July 2024.
引用
- Chan DKH, Siew BE, Lau J, et al. Time to return of bowel function following perioperative probiotics in colorectal cancer surgery (PICCS-1): study protocol for a randomized controlled trial. Trials. 2025. PMID: 39972354. doi:10.1186/s13063-025-08773-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。